Intellia Therapeutics Inc (NTLA)
Operating Income Growth
-2.51%
Quarterly · Period ending:
NTLA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-2.51%period ending
Latest reported-2.51%period ending
NTLA Quarterly Operating Income YoY % (-1822.47% → -2.51%)
Year-over-year change
High-resolution chart · PNG
NTLA operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -2.5128% | |
| 16.783% | |
| 27.6569% | |
| 22.9972% | |
| 20.8907% | |
| -5.9683% | |
| 2.4626% | |
| -10.4213% | |
| -5.0697% | |
| -1.8266% | |
| -27.074% | |
| -24.2367% | |
| -34.6212% | |
| 22.384% | |
| -36.8986% | |
| -46.5837% | |
| -42.4301% | |
| -210.7076% | |
| -89.6625% | |
| -156.1846% | |
| -108.9272% | |
| -40.4775% | |
| -42.4171% | |
| -10.9523% | |
| -20.2986% | |
| -38.8047% | |
| -43.5024% | |
| -5.0998% | |
| -16.3806% | |
| -6.148% | |
| 16.0591% | |
| -51.8047% | |
| -47.3122% | |
| -73.2314% | |
| -128.3774% | |
| -106.2492% | |
| -130.5931% | |
| -93.4269% | |
| -97.0861% | |
| -133.1718% | |
| -102.9807% | |
| -460.1674% | |
| -31.0814% | |
| -1,822.4719% |